Inventiva (IVA) Non-Current Deffered Revenue (2018 - 2025)
Inventiva's (IVA) quarterly Non-Current Deffered Revenue came in at $146669.5 in Q4 2025, up 28.28% year-on-year from $114339.7 in Q4 2024, and down 99.9% quarter-over-quarter from $142.6 million in Q2 2025.
Inventiva (IVA) Non-Current Deffered Revenue (2018 - 2025) Analysis & Trends
Inventiva's Non-Current Deffered Revenue history runs 5 years deep, the most recent figure standing at $146669.5 for Q4 2025.
- On a quarterly basis, Non-Current Deffered Revenue rose 28.28% year-over-year to $146669.5 in Q4 2025; TTM through Dec 2025 was $146669.5, a 28.28% increase from a year earlier, with the FY2025 full-year figure at $146669.5, up 28.28% from the prior year.
- Non-Current Deffered Revenue eased to $146669.5 in Q4 2025 per IVA's latest filing, from $142.6 million in the prior quarter.
- Across five years, Non-Current Deffered Revenue topped out at $142.6 million in Q2 2025 and bottomed at $56113.6 in Q4 2022.
- The 4-year median for Non-Current Deffered Revenue is $94827.8 (2023), against an average of $23.8 million.
- Across the five-year window, Non-Current Deffered Revenue jumped 51.81% in 2024 and climbed 28.28% in 2025, its largest moves.
- Year by year, Non-Current Deffered Revenue stood at $56113.6 in 2022, then jumped by 34.22% to $75315.8 in 2023, then surged by 51.81% to $114339.7 in 2024, then gained by 28.28% to $146669.5 in 2025.
- Per Business Quant, the three latest IVA Non-Current Deffered Revenue figures stand at $146669.5 (Q4 2025), $142.6 million (Q2 2025), and $114339.7 (Q4 2024).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Deffered Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 225.10 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Inventiva | 842.48 Mn | 842.48 Mn | - | 146,669.48 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 146,669.48 |
| Jun 30, 2025 | 142.63 Mn |
| Dec 31, 2024 | 114,339.71 |
| Dec 31, 2023 | 75,315.79 |
| Jun 30, 2023 | 66,424.39 |
| Dec 31, 2022 | 56,113.61 |
| Dec 31, 2018 | 1.91 Mn |